Madeline N Hayes

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Advanced Non Small Cell Lung Cancer

Inflammatory Response

Epidermal Growth Factor Receptor

Top Venues

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Alex Weiss, Cassandra D'Amata, Bret J Pearson, Madeline N Hayes
A syngeneic spontaneous zebrafish model of tp53 -deficient, EGFR vIII , and PI3KCA H1047R -driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo. eLife 13 (2024)
Alex Weiss, Cassandra D'Amata, Bret J Pearson, Madeline N Hayes
A syngeneic spontaneous zebrafish model of tp53 -deficient, EGFR vIII , and PI3KCA H1047R -driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo. eLife 13 (2024)
Alex Weiss, Cassandra D'Amata, Bret J Pearson, Madeline N Hayes
A syngeneic spontaneous zebrafish model of tp53 -deficient, EGFR vIII , and PI3KCA H1047R -driven glioblastoma reveals inhibitory roles for inflammation during tumor initiation and relapse in vivo. eLife 13 (2024)
Ivette Valencia-Sama, Lynn Kee, Gabriella Christopher, Michael Ohh, Mehdi Layeghifard, Adam Shlien, Madeline N Hayes, Meredith S Irwin
SHP2 inhibition with TNO155 increases efficacy and overcomes resistance of ALK inhibitors in neuroblastoma. Cancer research communications (2023)